We are live on ! Find out more
CBAY

Cymabay Therapeutics
CBAY

Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

120 hedge funds and large institutions have $416M invested in Cymabay Therapeutics in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 29 increasing their positions, 42 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

268% more call options, than puts

Call options by funds: $3.5M | Put options by funds: $951K

99% more capital invested

Capital invested by funds: $209M → $416M (+$207M)

26% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 23

5% more funds holding

Funds holding: 114 → 120 (+6)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

31% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 42

Holders
120
Holders Change
+6
Holders Change %
+5.26%
% of All Funds
2.42%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
29
Increased
29
Reduced
42
Closed
23
Calls
$3.5M
Puts
$951K
Net Calls
+$2.54M
Net Calls Change
+$2.16M

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$27M
2
BC
Boxer Capital
California
+$10.7M
3
Invesco
Invesco
Georgia
+$9.53M
4
BBA
Baker Bros. Advisors
New York
+$9.25M
5
Millennium Management
Millennium Management
New York
+$4.48M

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.09M
2
ECM
Engine Capital Management
New York
-$6.16M
3
SCM
Sio Capital Management
New York
-$6.1M
4
FCMI
Foresite Capital Management IV
California
-$5.65M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$5.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
101
Ameritas Investment Partners
Nebraska
$36K – – –
CAPTRUST Financial Advisors
102
CAPTRUST Financial Advisors
North Carolina
$25K +$18.7K +3,500 New
Osaic Holdings
103
Osaic Holdings
Arizona
$14K +$10.7K +2,000 New
Millennium Management
104
Millennium Management
New York
$12.2K +$4.48M +838,446 +99%
SFS
105
Sowell Financial Services
Arkansas
$12K +$8.21K +1,535 +1,535%
Nisa Investment Advisors
106
Nisa Investment Advisors
Missouri
$10K – – –
Royal Bank of Canada
107
Royal Bank of Canada
Ontario, Canada
$9K -$5.57K -1,042 -45%
GRP
108
Global Retirement Partners
California
$9K – – –
IA
109
IFP Advisors
Florida
$5K +$3.48K +650 New
CG
110
Cutler Group
California
$4K – – –
PNC Financial Services Group
111
PNC Financial Services Group
Pennsylvania
$4K – – –
GWS
112
Glassman Wealth Services
Virginia
$4K +$1.6K +300 +128%
PCM
113
Penserra Capital Management
California
$4K +$3.13K +586 New
Federated Hermes
114
Federated Hermes
Pennsylvania
$3K -$898 -168 -32%
Daiwa Securities Group
115
Daiwa Securities Group
Japan
$3K – – –
APA
116
American Portfolios Advisors
New York
$2.53K – – –
FFA
117
Founders Financial Alliance
North Carolina
$1K +$1.07K +200 New
GT
118
Glenmede Trust
Pennsylvania
$1K +$1.46K +273 New
ECM
119
Engine Capital Management
New York
– -$6.16M -1,766,196 Closed
IC
120
Ikarian Capital
Texas
– -$5.34M -1,529,830 Closed
Arrowstreet Capital
121
Arrowstreet Capital
Massachusetts
– -$3.62M -1,036,294 Closed
Verition Fund Management
122
Verition Fund Management
Connecticut
– -$2.1M -601,828 Closed
Point72 Asset Management
123
Point72 Asset Management
Connecticut
– -$2.01M -576,638 Closed
CS
124
Credit Suisse
Switzerland
– -$1.71M -490,223 Closed
Hudson Bay Capital Management
125
Hudson Bay Capital Management
Connecticut
– -$1.17M -335,000 Closed
2 3 4
5
6

CBAY Hedge Fund Activity: Q3 2020 in Review

120 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Cymabay Therapeutics (CBAY) for Q3 2020, worth a combined $416M — up 99% from $209M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new CBAY positions and 23 closed out — a net gain of 6 holders — while 29 added to existing stakes and 42 trimmed.

The largest buyer was Avoro Capital Advisors, adding an estimated $27M. The largest seller was D.E. Shaw & Co, cutting an estimated $9.09M.

  • 120 institutional investors held Cymabay Therapeutics (CBAY) as of Q3 2020, up from 114 in Q2 2020.
  • Funds reported $416M of Cymabay Therapeutics stock for Q3 2020, up 99% quarter-over-quarter.
  • 29 funds opened new Cymabay Therapeutics positions in Q3 2020 and 23 closed out, a net change of +6 holders.
  • The largest Cymabay Therapeutics buyer in Q3 2020 was Avoro Capital Advisors, an estimated $27M added.
  • The largest Cymabay Therapeutics seller in Q3 2020 was D.E. Shaw & Co, an estimated $9.09M sold.

Based on aggregated 13F filings for Q3 2020.